TUCSON, Ariz., Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and ...

TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate ...

TUCSON, Ariz., March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m. Eastern Time to ...

Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly. Sepsis is a potentially fatal response from the body to an infection, and 1.7 ...

This new testing platform will speed up health checks by determining whether asymptomatic people have COVID-19 antibodies in 30 minutes. On Tuesday, the two companies announced that the Food and Drug ...

Accelerate Diagnostics (NASDAQ:AXDX) said Friday it priced an underwritten public offering of units and a concurrent private placement to raise up to $15 million. Shares -33.33% at $1.07 in early ...

BD (Becton, Dickinson and Co.) announced Aug. 15 a commercial collaboration under which the Franklin Lakes-based company will offer Accelerate Diagnostics Inc.’s rapid tests through its global sales ...

In response toreceivingFDA marketing authorization for two products, shares of Accelerate Diagnostics (NASDAQ: AXDX), a company focused onthe rapid diagnosis of infectious diseases, rose by 11% as of ...

Accelerate Diagnostics ( (AXDX)) has released its Q3 earnings. Here is a breakdown of the information Accelerate Diagnostics presented to its investors. Accelerate Diagnostics, Inc. is a company ...

TUCSON, Ariz., Aug. 17, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate Diagnostics") today announced that it has commenced an underwritten public offering of shares of ...